Chandra Bhagat Pharma H1 FY27 Net Profit Surges Over Tenfold YoY
Chandra Bhagat Pharma Ltd · Financial Result · 13 Nov 2026, 11:47 pm
Chandra Bhagat Pharma H1 FY27 Net Profit Surges Over Tenfold YoY Chandra Bhagat Pharma reported total revenue from operations of ₹8,012.92 lakhs for the half-year ended 30th Sep'26, jumping 213.67% YoY from ₹2,554.60 lakhs in H1 FY26. Net profit surged more than tenfold to ₹264.11 lakhs compared to ₹22.87 lakhs in the previous corresponding period. Basic and diluted EPS improved to ₹3.50 against ₹0.30 YoY. Cash flow from operating activities stood at negative ₹196.62 lakhs due to working capital changes. Total equity rose to ₹3,576.75 lakhs as of 30th Sep'26.
Original exchange filing (PDF)
More announcements from Chandra Bhagat Pharma Ltd
- Outcome of the Board Meeting held on 13th November, 2026 for approval of un-audited result as on 30th September, 2026. · 13 Nov 2026
- Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Result for .... · 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Ramkant Dave · 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chintan Vijay Makhecha · 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Chandravadan Bhagat & PACs · 26 Oct 2026
- Please find attached disclosure under Reg 30 of SEBI (LODR) Regulations, 2015 for your reference. · 22 Oct 2026
- Certificate for Non_Applicability of Corporate Governance Certificate for the quarter ended 30th September, 2026. · 21 Oct 2026
- The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis. · 13 Oct 2026
